SWOG clinical trial number
SWOG-7634

Evaluation of MeCCNU plus -2'-Deoxythioguanosine and mitomycin-C plus -2'-Deoxythioguanosine in the Treatment of Refractory Disseminated Colorectal Carcinoma

Closed
Abbreviated Title
Evaluation of MeCCNU plus -2'-Deoxythioguanosine and mitomycin-C plus -2'-Deoxythioguanosine in the Treatment of Refractory Disseminated Colorectal Carcinoma
Activated
11/22/1976
Closed
08/08/1978

Publication Information Expand/Collapse

1981

Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer: A Southwest Oncology Group study.

RG Gagliano;FJ Panettiere;CD Haas;L Baker;J Hewlett;WJ Stuckey;RM O'Bryan;R Bottomley;LK Heilbrun Cancer Clin Trials 4:401-405

1979

Evaluation of BTdGR (B) with either Methyl-CCNU (Me) or Mitomycin C (Mi) in the management of disseminated colorectal carcinoma.

FJ Panettiere;R Gagliano;L Heilbrun AACR #277